logo-loader

Ellex Medical Lasers to outline capital plans, shares on the fly

Published: 13:00 17 Sep 2013 AEST

no_picture_pai

Ellex Medical Lasers (ASX: ELX) operates in the current market 'hot spot' of the medical device sector, with its shares close to doubling recently from the May lows.

Ellex Medical is now heading to market with a capital raising, with the ASX granting the company a trading halt - with its shares placed in pre-open.

The company develops, manufactures and markets lasers and diagnostic equipment for the treatment of eye disease to a growing global market.

Highlighting the interest in ophthalmic lasers, Abbot (NYSE: ABT) acquired Optimedica Corporation for US$250 million upfront and further US$150 million in earn out.

Ellex Medical's revenue for FY13 was $42.8 million, which is dispersed across the globe and includes around a quarter from both the Americas and Japan, and about a fifth from Australia.

The halt will last until the earlier of an announcement being made to the market, or the opening of trade on Thursday 19th September 2013.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

3 hours, 12 minutes ago